In our ongoing study, TRF intervention across HFD and genetically induced obesity resulted in the downregulation of diacylglycerol O-acyltransferase 2 (Dgat2) in muscle. The gene discussed is DGAT2; the disease is obesity due to melanocortin 4 receptor deficiency.